442 related articles for article (PubMed ID: 16320688)
21. Evaluation of a new paraffin-reactive CD7 T-cell deletion marker and a polymerase chain reaction-based T-cell receptor gene rearrangement assay: implications for diagnosis of mycosis fungoides in community clinical practice.
Ormsby A; Bergfeld WF; Tubbs RR; Hsi ED
J Am Acad Dermatol; 2001 Sep; 45(3):405-13. PubMed ID: 11511839
[TBL] [Abstract][Full Text] [Related]
22. CD20 positive mycosis fungoides: a case report.
Sen F; Kang S; Cangiarella J; Kamino H; Hymes K
J Cutan Pathol; 2008 Apr; 35(4):398-403. PubMed ID: 18261116
[TBL] [Abstract][Full Text] [Related]
23. Mycosis fungoides and the Sézary syndrome.
Kim YH; Hoppe RT
Semin Oncol; 1999 Jun; 26(3):276-89. PubMed ID: 10375085
[TBL] [Abstract][Full Text] [Related]
24. Clinicopathological spectrum of mycosis fungoides type cutaneous T-cell lymphoma.
Shaikh ZI; Rahman SB
J Coll Physicians Surg Pak; 2006 Mar; 16(3):171-4. PubMed ID: 16542594
[TBL] [Abstract][Full Text] [Related]
25. [Mycosis fungoides and Sézary syndrome. A retrospective study of 60 patients with correlation between histologic classification and survival time].
Hödl S
Z Hautkr; 1986 Jul; 61(14):993-1013. PubMed ID: 3751216
[TBL] [Abstract][Full Text] [Related]
26. Folliculotropic mycosis fungoides (stage IIA) progressing to Sézary syndrome: a case report.
Agar N; Whittaker SJ
Br J Dermatol; 2008 Nov; 159(5):1197-9. PubMed ID: 18764843
[TBL] [Abstract][Full Text] [Related]
27. T-cell receptor-gamma gene analysis in evolving to advancing cutaneous T-cell lymphoma.
Foo CC; Tang MB; Chong TK; Sun YJ; Tan SH
Australas J Dermatol; 2007 Aug; 48(3):156-60. PubMed ID: 17680965
[TBL] [Abstract][Full Text] [Related]
28. Simplified flow cytometric assessment in mycosis fungoides and Sézary syndrome.
Hristov AC; Vonderheid EC; Borowitz MJ
Am J Clin Pathol; 2011 Dec; 136(6):944-53. PubMed ID: 22095381
[TBL] [Abstract][Full Text] [Related]
29. [Analysis of cloning rearrangement of T-cell receptor gamma gene in primary cutaneous lymphoma].
Pawlaczyk M; Kistowska M; Poreba E; Filas V; Breborowicz J; Goździcka-Józefiak A
Pol Merkur Lekarski; 2003 Nov; 15(89):420-3. PubMed ID: 14969134
[TBL] [Abstract][Full Text] [Related]
30. Clinical characteristics and course of CD8+ cytotoxic variant of mycosis fungoides: a case series of seven patients.
Nikolaou VA; Papadavid E; Katsambas A; Stratigos AJ; Marinos L; Anagnostou D; Antoniou C
Br J Dermatol; 2009 Oct; 161(4):826-30. PubMed ID: 19558552
[TBL] [Abstract][Full Text] [Related]
31. Management of mycosis fungoides. Part 1. Diagnosis, staging, and prognosis.
Smith BD; Wilson LD
Oncology (Williston Park); 2003 Sep; 17(9):1281-8. PubMed ID: 14569854
[TBL] [Abstract][Full Text] [Related]
32. Overexpression of c-myb in leukaemic and non-leukaemic variants of cutaneous T-cell lymphoma.
Poenitz N; Simon-Ackermann J; Gratchev A; Qadoumi M; Klemke CD; Stadler R; Kremer A; Radenhausen M; Henke U; Assaf C; Utikal J; Goerdt S; Dippel E
Dermatology; 2005; 211(2):84-92. PubMed ID: 16088151
[TBL] [Abstract][Full Text] [Related]
33. Fine-needle aspiration biopsy in the evaluation of lymphadenopathy associated with cutaneous T-cell lymphoma (mycosis fungoides/Sézary syndrome).
Galindo LM; Garcia FU; Hanau CA; Lessin SR; Jhala N; Bigler RD; Vonderheid EC
Am J Clin Pathol; 2000 Jun; 113(6):865-71. PubMed ID: 10874888
[TBL] [Abstract][Full Text] [Related]
34. Expression of selected T-cell antigens in the skin infiltration in primary cutaneous T-cell lymphomas.
Wojnowska D; Lecewicz-Toruń B; Chodorowska G; Juszkiewicz-Borowiec M; Skomra D
Ann Univ Mariae Curie Sklodowska Med; 2001; 56():237-42. PubMed ID: 11977317
[TBL] [Abstract][Full Text] [Related]
35. Value of clonality studies of cutaneous T lymphocytes in the diagnosis and follow-up of patients with mycosis fungoides.
Delfau-Larue MH; Petrella T; Lahet C; Lebozec C; Bagot M; Roudot-Thoraval F; Dalac S; Farcet JP; Wechsler J
J Pathol; 1998 Feb; 184(2):185-90. PubMed ID: 9602710
[TBL] [Abstract][Full Text] [Related]
36. Diagnostic and prognostic significance of clonal T-cell receptor beta gene rearrangements in lymph nodes of patients with mycosis fungoides.
Bakels V; Van Oostveen JW; Geerts ML; Gordijn RL; Walboomers JM; Scheffer E; Meijer CJ; Willemze R
J Pathol; 1993 Jul; 170(3):249-55. PubMed ID: 8133398
[TBL] [Abstract][Full Text] [Related]
37. Transformed mycosis fungoides: clinicopathological features and outcome.
Barberio E; Thomas L; Skowron F; Balme B; Dalle S
Br J Dermatol; 2007 Aug; 157(2):284-9. PubMed ID: 17573879
[TBL] [Abstract][Full Text] [Related]
38. [Mycosis fungoides in childhood and adolescence with clonal T-cell receptor gamma gene rearrangement. Two cases].
Krokowski M; Winzer M; Lange K; Thorns C; Gafumbegete E; Feller AC; Merz H
Hautarzt; 2003 Jun; 54(6):536-40. PubMed ID: 12759739
[TBL] [Abstract][Full Text] [Related]
39. T-cell clonality analysis in biopsy specimens from two different skin sites shows high specificity in the diagnosis of patients with suggested mycosis fungoides.
Thurber SE; Zhang B; Kim YH; Schrijver I; Zehnder J; Kohler S
J Am Acad Dermatol; 2007 Nov; 57(5):782-90. PubMed ID: 17646032
[TBL] [Abstract][Full Text] [Related]
40. The prognosis of early mycosis fungoides is not influenced by phenotype and T-cell clonality.
Massone C; Crisman G; Kerl H; Cerroni L
Br J Dermatol; 2008 Sep; 159(4):881-6. PubMed ID: 18644018
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
